Onkos Diagnósticos Moleculares
PrivateLast Round
Grant
May 1, 2025
Company Overview
Onkos Diagnósticos Moleculares operates in Healthcare & Life Sciences and is based in Ribeirão Preto. Its latest recorded funding round was a Grant round in May 2025.
Onkos Diagnósticos Moleculares is a biotechnology company that develops molecular diagnostic tests for oncology, specializing in gene expression profiling and genetic markers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Onkos Diagnósticos Moleculares Comparables
Compare Onkos Diagnósticos Moleculares with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GeneproDX | 86% | |
| Veracyte | 73% | |
| OncoTag | 72% |
For institutional investors. Book with your work email.
Onkos Diagnósticos Moleculares Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2025 | ||||
| Accelerator | Nov 1, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Onkos Diagnósticos Moleculares Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eretz.bio | Accelerator |
| Conselho Nacional de Desenvolvimento Científico e Tecnológico | Grant |
| Financiadora de Estudos e Projetos | Grant |
| SUPERA Parque de Inovação e Tecnologia | Accelerator |
| FAPESP | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Grew 25% QoQ, from 32 to 40 employees.
- May 13, 2025
Grew 15% QoQ, from 33 to 38 employees.
For institutional investors. Book with your work email.
Onkos Diagnósticos Moleculares Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Onkos Diagnósticos Moleculares's valuation, stock price, and market status.
Is Onkos Diagnósticos Moleculares a public or private company?
Onkos Diagnósticos Moleculares is a private company.
What is the current stock price of Onkos Diagnósticos Moleculares?
Onkos Diagnósticos Moleculares is a private company, so its shares have no public market price. Caplight tracks Onkos Diagnósticos Moleculares's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Onkos Diagnósticos Moleculares worth (valuation)?
Valuation information for Onkos Diagnósticos Moleculares is not publicly available.
Can I buy Onkos Diagnósticos Moleculares stock?
Onkos Diagnósticos Moleculares shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Onkos Diagnósticos Moleculares's last funding round?
Onkos Diagnósticos Moleculares's most recent funding round was Grant on May 1, 2025.
Who are the main investors in Onkos Diagnósticos Moleculares?
Key investors in Onkos Diagnósticos Moleculares include Eretz.bio, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Financiadora de Estudos e Projetos, SUPERA Parque de Inovação e Tecnologia, FAPESP.
Will Onkos Diagnósticos Moleculares IPO soon?
No public IPO plans have been announced for Onkos Diagnósticos Moleculares.
How can I track Onkos Diagnósticos Moleculares secondary market activity?
Caplight tracks bids, offers, and trades in Onkos Diagnósticos Moleculares's shares on secondary markets.